Introduction
Periodontal disease results from an interaction between the host's defense mechanisms and the microorganisms that are present in dental plaque biofilms. Although bacteria play indispensable roles in the initiation of the disease, the subsequent progression and severity of the disease are strongly influenced by the host immune response. Periodontitis affects tooth-supporting bone and soft tissues and is a major cause of tooth loss. Periodontitis lesions are characterized as a predominant B cell response; however, T cells have an essential immunoregulatory role [1] . In addition, several studies have suggested the involvement of autoreactive T cells and autoantibodies in the pathogenesis of periodontitis [2] [3] [4] [5] .
Because it is well known that T cells are a heterogeneous population, and a balance between functionally different T cell subsets is crucial in immune regulation, a series of studies have attempted to associate an impaired balance between each T cell subset and periodontal disease progression. Nevertheless, it seems difficult to reveal this association because each T cell subset exhibits beneficial and detrimental properties depending on disease conditions [6] .
In this review, we will discuss the presence and the role of various T cell subsets, including CD8 + cytotoxic T cells, CD4 + T helper cells (Th1, Th2, and Th17), regulatory T cells, and natural killer T (NKT) cells in the pathogenesis of periodontitis. To this end, we will give an overview of the human studies that analyzed specimens such as gingival tissues, gingival crevicular fluid, and peripheral blood obtained from periodontitis patients. In addition, we summarize the current knowledge about rodent models with age-related or experimental periodontitis induced by major periodontopathic bacteria (Table 1) .
CD4 + Helper and CD8 + Cytotoxic T Cell Lineages

CD4
+ and CD8 + T cells differentiate from CD4 + CD8 + doublepositive precursors in the thymus and exhibit distinct antigen specificities and functions. CD4 + T cells are major histocompatibility complex (MHC)-II-restricted and preprogrammed for helper functions, whereas CD8 + T cells are MHC-Irestricted and preprogrammed for cytotoxic functions. Because the ratio of CD4 + to CD8 + T cells is one of the indexes to determine the character of immune responses, its association with periodontal disease progression has been extensively examined. Some researchers analyzed the cells extracted from human gingival tissues and found decreased CD4/CD8 ratios in periodontitis lesions compared with healthy sites or peripheral blood [23, 24] . According to histologic analysis, some studies reported decreased CD4/CD8 ratios in periodontitis lesions compared with gingivitis or healthy sites [25, 26] , whereas some reported increased CD4/CD8 ratios [27, 28] , and others found no differences in the ratios [29, 30] . As discussed below, contradictory results obtained in human studies could be attributable to differences in methodology between studies, and the timing of sampling relative to disease activity.
A few studies have examined the impact of CD4 + and CD8 + T cells on periodontopathic bacteria-induced alveolar bone resorption in mouse models. Baker et al showed that mice lacking MHC-II-restricted CD4 + T cells, but not MHC-Irestricted CD8 + T cells, were resistant to alveolar bone loss induced by Porphyromonas gingivalis oral infection [7] . In addition, oral Aggregatibacter actinomycetemcomitans challenge of NOD/SCID mice transplanted with peripheral blood lymphocytes from periodontitis patients (HuPBL-NOD/SCID mice) demonstrated that CD4 + T cells, but not CD8 + T cells, were essential mediators of alveolar bone destruction [8] . These findings in mouse models suggest that CD4 + T cells contribute to bone destruction in periodontal disease.
+ T Helper Subsets (Th1, Th2, and Th17)
Several CD4 + T cell subsets have been identified based on their distinct cytokine and transcription factor profiles [31] . Peptide affinity for MHC-II, T cell receptor activation, the expressed costimulatory molecules, and the cytokines secreted by dendritic cells collectively determine the signal strength that influences the differentiation of naïve T helper cells into Th1, Th2, Th17, or inducible regulatory T cells. Th1 and Th2 are classic T helper subsets that are characterized by the transcription factors T-bet and GATA-3, respectively. Th1 differentiation is accelerated by interleukin (IL)-12, while exposure to IL-4 drives Th2 differentiation. Th1 cells secrete IL-2 and interferon (IFN)-γ, which promote cell-mediated immunity by activating macrophages, CD8 + T cells, and NK cells.
The Th1 response is essential in immune defense against intracellular bacteria, viruses, and tumors, but possibly promotes autoimmune disease. However, the Th2 response produces IL-4, IL-5, IL-6, IL-10, and IL-13, which mediate humoral immunity by promoting B cell proliferation, differentiation, and antibody production. The Th2 response is involved in parasitic worm immunity and allergic inflammatory responses, including airway hyper-reactivity. Th17 is a recently identified T helper subset that expresses the transcription factors RORγt and RORα and produces IL-17A, IL-17 F, IL-21, IL-22, and IL-26. It has been reported that cytokines such as IL-1β, IL-6, IL-21, IL-23, and TGF-β are important for Th17 differentiation and development.
Th17 cells play a protective role against extracellular bacteria and fungi but are also related to several autoimmune and inflammatory disorders such as the inflammatory bone destructive disorder rheumatoid arthritis [32] . Importantly, although Th1 and Th2 cells have inhibitory effects on osteoclastogenesis through IFN-γ and IL-4, respectively, Th17 is defined as an osteoclastogenic T helper subset because it induces receptor activator of nuclear factor-κB ligand (RANKL) on osteoclastogenesis-supporting cells such as osteoblasts and synovial fibroblasts. Additionally, IL-17 enhances local inflammation and increases the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, IL-1, and IL-6, which further promote RANKL expression. Furthermore, Th17 cells themselves express RANKL and may participate directly in osteoclastogenesis [33, 34••] .
Until the discovery of Th17, researchers had focused on the Th1/Th2 paradigm and attempted to identify either subset as causative for the progression of periodontal disease. In humans, numerous studies have supported the hypothesis that Th1 cells are associated with stable lesions and Th2 cells are associated with progressive lesions [35] [36] [37] [38] [39] [40] . In contrast, several studies have demonstrated that upregulation of Th1 responses or downregulation of Th2 responses are involved in periodontal tissue destruction [41] [42] [43] . Moreover, others have shown a comparable presence of Th1 and Th2 cytokines in human periodontitis lesions [44] [45] [46] [47] [48] [49] .
To clarify the functional role of Th1 and Th2 in periodontal disease, several rodent models have been developed. Mice with A. actinomycetemcomitans-induced periodontitis demonstrated upregulation of Th1 cytokines (IFN-γ and IL-12) in the early stage and that of Th2 cytokines (IL-4 and IL-10) in the late stage, indicating the involvement of each T cell subset in different disease stages [9] . Destructive effects of Th1 and Th2 cytokines were suggested in an experiment that showed that IFN-γ-and IL-6-deficient mice were resistant to P. gingivalis-induced alveolar bone loss [7] . However, the pathogenic role of Th1 cells, as opposed to Th2 cells, was indicated in a study using HuPBL-NOD/SCID mice with A. actinomycetemcomitans-induced alveolar bone resorption, in which bone loss was associated with CD4 + T cells expressing IFN-γ rather than IL-4. In addition, the injection of IFN-γ into the mice further enhanced the bone loss [10] . Furthermore, adoptive transfer of antigen-specific Th1 cells but not Th2 cells enhanced alveolar bone destruction in rats injected with the A. actinomycetemcomitans 29-kDa outer membrane protein and lipopolysaccharide (LPS) into gingiva [11] . In contrast, a pathogenic role of the Th2 response was proposed in a study demonstrating that Tannerella forsythiainduced alveolar bone loss was accompanied by an increase in IL-5 but not of IFN-γ or IL-17 [12] . However, the protective roles of the Th1 and Th2 subsets were suggested in several articles, as described below. Oral gavage of P. gingivalis-derived antigen plus CpG oligodeoxynucleotides decreased their susceptibility to P. gingivalis-induced alveolar bone destruction, which was accompanied by upregulated production of Th1 and Th2 cytokines such as IFN-γ, IL-4, IL-5, and IL-6 in antigen-specific CD4 + T cells [13] . In addition, deficiency in the individual Th1 or Th2 cytokines (IFN-γ, IL-12p40, IL-4, or IL-10) resulted in enhanced, age-related alveolar bone loss [14] .
It has become apparent that the pathogenesis of periodontitis cannot be fully explained through the prism of the Th1/ Th2 paradigm; therefore, the discovery of Th17 has been expected to clarify the complex pathogenesis of periodontitis. Numerous reports have shown an elevated level of IL-17 in gingival tissues or gingival crevicular fluid from periodontitis lesions compared with healthy sites [50] [51] [52] [53] [54] [55] [56] [57] . These reports also demonstrated the association of other Th17-related cytokines (eg, IL-1β, IL-6, IL-21, and IL-23) with periodontitis. The protective role of Th17 cells against periodontal tissue destruction was suggested by a study using mice deficient for IL-17RA, a member of the IL-17 receptor family. The mice were susceptible to P. gingivalis-induced alveolar bone loss because of deficits in neutrophil migration [15] . However, mice lacking functional IL-17 or IL-23 are resistant to joint bone erosion induced by collagen-induced arthritis, which implies a destructive aspect of Th17 cells [63, 64] . The apparent difference in these studies may be due to the importance of Th17 cells in the control of infection (eg, periodontitis), but not in noninfectious diseases (eg, autoimmune arthritis).
Collectively, human and animal studies suggest that each T-helper subset possibly has beneficial and detrimental aspects in the pathogenesis of periodontal disease; thereby, an appropriate balance between the functionally different subsets may be important to eliminate infection and abrogate tissue destruction. The precise role of Th17 cells in physiological and pathologic conditions, including actions on innate immunity and osteoclastogenesis, should be further explored because Th17 cells and their cytokines are consistently increased in human periodontitis lesions.
Regulatory T Cells
Immunological self-tolerance is supported by several mechanisms: physical elimination (clonal deletion), functional inactivation (anergy), and T cell-mediated suppression. + T cells in lymphocytes extracted from gingival tissues was higher than that from peripheral blood in periodontitis patients [72] . However, the reason for the discrepancy has not been clarified.
In rats, A. actinomycetemcomitans-induced experimental periodontitis did not change the proportion of Foxp3 + cells in draining node lymphocytes [16] . In contrast, mice with A. actinomycetemcomitans-induced alveolar bone loss showed an increased number of Foxp3 + CD4
+ T cells and elevated expression of CTLA-4, IL-10, and TGF-β in gingival tissues [17] . It is noteworthy that this study also showed that the inhibition of Tregs by anti-GITR treatment downregulated the Treg-related molecules, but upregulated IFN-γ and RANKL, and further enhanced bone loss without changing the bacterial load. These data indicate the possibility that Tregs attenuate the severity of periodontitis without impairing infection control. More recent research demonstrated that all-trans retinoic acid (ATRA) suppressed P. gingivalis-induced alveolar bone loss and inflammatory cell infiltration, which was accompanied by an increase of CTLA-4-mediated suppression is considered to be a central mechanism of Foxp3 + Treg function [73] . Immunohistologic analysis showed only a small number of CTLA-4 + cells in periodontitis lesions and healthy sites [74, 75] . In rats, administration of CTLA4-immunoglobulin fusion proteins (CTLA4Ig) abrogated the alveolar bone resorption that was induced by gingival injection of A. actinomycetemcomitansderived antigens, suggesting a protective role of CTLA-4 in periodontitis [11] . Anti-inflammatory cytokines are an additional mechanism through which regulatory T cells control inflammation. IL-10 is produced by various cell populations, including regulatory T cells and T-helper subsets. IL-10 gene expression was higher in periodontitis tissues than in healthy sites or peripheral blood mononuclear cells [70, 76] . In addition, IL-10 + cells were widely distributed in periodontitis lesions [77] . The protective role of IL-10 was suggested by studies where IL-10-deficient mice displayed increased susceptibility to age-related or P. gingivalis-induced alveolar bone loss [14, 20] 
NKT Cells
Invariant NKT (iNKT) cells are characterized by the coexpression of the natural killer cell receptor, NK1.1 (CD161), and restricted T cell receptors, Vα24Jα18 in humans and Vα14Jα18 in mice. Multiple iNKT cell populations differ in their function, location, and phenotype. iNKT cells typically recognize glycolipids that are presented by CD1d molecules, which are predominantly expressed on antigen-presenting cells (eg, dendritic cells, macrophages, and B cells) [89] . It has been reported that iNKT cells recognize antigens derived from bacteria such as Borrelia burgdorferi, Sphingomonas spp, Streptococcus pneumonia, and group B streptococcus [90] [91] [92] . In addition, some selfantigens are proposed to contribute to iNKT cell function [93] . iNKT cells rapidly respond to antigens and release substantial amounts of IFN-γ and IL-4, which subsequently activate other lymphocytes and shape the course of adaptive responses. Thus, iNKT cells play important functions in autoimmune disease, cancer, infection, and inflammation [94] Several studies have reported the involvement of iNKT and CD1d + cells in human periodontitis. Yamazaki et al used single-strand conformation polymorphism analysis to demonstrate that the proportion of NKT cells was elevated in periodontitis lesions compared with gingivitis lesions [95] . Immunohistologic analysis revealed that CD1d + and iNKT cells were increased in periodontitis lesions, and a fraction of the CD1d + cells was identified as CD19 + B cells [96] . A more recent report showed increased iNKT cells in gingival tissues with aggressive periodontitis, but not chronic periodontitis, compared with healthy biopsies [97] .
The pathogenic role of NKT cells in periodontal bone destruction was suggested by experiments utilizing mice with either a deficiency or activation of NKT cells. CD1d -/-mice, which lack Vα14 NKT cells, were completely resistant to P. gingivalis-induced alveolar bone resorption. In contrast, administration of α-galactosylceramide, which activates NKT cells in a CD1d-dependent manner, further accelerated P. gingivalis-induced bone resorption [22••]. However, it is still unknown whether P. gingivalis-derived antigens were directly recognized by NKT cells in the mouse models. To apply the pathogenicity of NKT cells in mice to humans, it should be determined whether the NKT cells observed in human periodontitis lesions are sufficiently activated to skew immune responses.
Conclusions
It is clear that T cells in periodontal tissues play a crucial role in infection control and tissue destruction in periodontal disease, whereas the mechanism of immune regulation underlying the disease is highly complicated. In humans, numerous studies have revealed phenomena that occur in periodontitis lesions by using a variety of materials and methods. These studies provide valuable insights into the T cell-mediated immune regulation of the pathogenesis of periodontitis, but they have also shown inconsistent results, which may be attributed to differences in the experimental approaches and a lack of evaluation of disease activity. Because it is considered that a diseased site exhibits an active state at times, but inactive state at other times, the change of disease activity could affect the immune responses at local sampling sites. What is not addressed in clinical studies because of ethical considerations can possibly be examined in research with animal models.
Several studies on experimental periodontitis in mice with deletions of T cell-related genes have implicated that an optimal balance between functionally different T cells may be more important in the protection against periodontal tissue destruction than a strong, polarized response on either side. This framework could be applied to humans, although it should be noted that these periodontitis models do not represent all aspects of human periodontal disease. Gemmell et al proposed that T cells are homeostatic in maintaining a balance between the host and biofilm, and disease progression occurs if the homeostatic balance is disrupted by environmental influences that lead to increased pathogens or depression of the host's defense mechanisms [1] .
Finally, we briefly summarize the potential role of T cells in inflammatory responses and bone destruction in Fig. 1 , where the T cells form a cytokine network that affects other immune and resident cells. Current approaches in periodontal treatment include the removal of bacteria and their components rather than modulating the host response. However, a deeper understanding of how T cells regulate the balance between protective and destructive immune responses may contribute to the development of new therapeutic modalities for periodontal disease in the future. 
